Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × NETWORK × darlin protein, Dictyostelium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Radiotherapy 124 Cyclophosphamide 99 Cisplatin 96 Doxorubicin 91 Vincristine 69 Filgrastim 55 Etoposide 53 Paclitaxel 51 Carboplatin 50 Fluorouracil 48 Methotrexate 45 Dexamethasone 43 Prednisone 38 Cytarabine 38 Leucovorin 35 Granulocyte Colony-Stimulating Factor 31 Docetaxel 31 Radiation 27 Ifosfamide 25 Tamoxifen 24 Daunorubicin 23 Calcium Dobesilate 23 Specimen Handling 22 Gemcitabine 21 Platinum 20 Mercaptopurine 20 Magnetic Resonance Spectroscopy 20 Chemotherapy, Adjuvant 20 1,2-diaminocyclohexaneplatinum II citrate 20 Goserelin 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡